dexamethasone · Eyepoint Pharms · NDA 208912
Dexycu Kit
Earliest generic entry, as listed
23 Jun 2039
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 11097061.
Listed patents · 5 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11097061 | drug product, use U-3418 · sets the listed date | 23 Jun 2039 |
| US 10022502 | use U-2340 | 22 Jun 2034 |
| US 10028965 | use U-2340 | 23 May 2034 |
| US 10159683 | drug product | 23 May 2034 |
| US 10799642 | drug product | 11 May 2032 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208912 · 001 · RLD · discontinued | suspension, intraocular | 9% | 23 Jun 2039 |